Market cap
$980 Mln
Market cap
$980 Mln
Revenue (TTM)
$148 Mln
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
10 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
14.9
Debt to Equity
--
Book Value
$38.1
EPS
$-0.9
Face value
--
Shares outstanding
13,407,358
CFO
$318.25 Mln
EBITDA
$460.68 Mln
Net Profit
$-10.70 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Global Medical REIT (GMRE)
| 6.0 | 5.7 | 1.2 | -6.6 | -8.6 | -13.1 | -- |
|
BSE Sensex*
| -7.9 | 6.3 | -6.4 | -3.5 | 8.5 | 9.9 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Global Medical REIT (GMRE)
| -12.6 | -30.2 | 17.1 | -46.6 | 43.5 | 5.8 | 60.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Global Medical REIT (GMRE)
|
35.8 | 979.8 | 148.2 | -12.1 | 10.4 | -2.3 | -- | 1.2 |
| 10.7 | 12,224.1 | 3,376.0 | 1,472.0 | 46.2 | 12.5 | 8.3 | 1.2 | |
| 39.2 | 8,888.1 | 1,132.0 | 327.5 | 29.2 | 12.1 | 27.5 | 3.4 | |
| 47.8 | 13,402.1 | 1,619.5 | 891.8 | 85.7 | 18.8 | 15.1 | 2.9 | |
| 19.9 | 6,867.7 | 1,149.2 | -201.3 | 8.3 | -4.3 | -- | 1.5 | |
| 138.5 | 14,154.1 | 2,266.2 | 587.2 | 32.4 | 57 | 24.3 | 14.1 | |
| 46.1 | 14,408.1 | 1,238.9 | 632.1 | 71.4 | 11.9 | 22.7 | 2.7 | |
| 16.5 | 11,325.7 | 2,822.5 | 71.4 | 19.3 | 0.9 | 162.9 | 1.5 | |
| 20.7 | 6,265.1 | 484.5 | 474.4 | 20.8 | 23.8 | 44.8 | 2.9 | |
| 18.3 | 6,848.8 | 1,880.2 | 411.5 | 92.9 | 6.2 | 15.7 | 1.0 |
Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Address: 7373 Wisconsin Avenue, Bethesda, MD, United States, 20814
Chairman, President & CEO
Mr. Jeffrey M. Busch
CFO & Treasurer
Mr. Robert J. Kiernan CPA
Headquarters
Bethesda, MD
Website
The share price of Global Medical REIT Inc (GMRE) is $35.77 (NYSE) as of 24-Apr-2026 09:30 EDT. Global Medical REIT Inc (GMRE) has given a return of -8.57% in the last 3 years.
Since, TTM earnings of Global Medical REIT Inc (GMRE) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-37.23
|
0.88
|
|
2024
|
3.11
|
0.04
|
|
2023
|
1.41
|
0.05
|
|
2022
|
1.30
|
0.04
|
|
2021
|
64.79
|
1.79
|
The 52-week high and low of Global Medical REIT Inc (GMRE) are Rs 194.46 and Rs 29.05 as of 06-May-2026.
Global Medical REIT Inc (GMRE) has a market capitalisation of $ 980 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Global Medical REIT Inc (GMRE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.